» Articles » PMID: 9191009

Expression of E-cadherin and N-cadherin in Surface Epithelial-stromal Tumors of the Ovary Distinguishes Mucinous from Serous and Endometrioid Tumors

Overview
Journal Hum Pathol
Specialty Pathology
Date 1997 Jun 1
PMID 9191009
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

This study examines the expression of E-cadherin and N-cadherin in the most common epithelial tumors of the ovary. The homotypic interactions of distinctive members of the cadherin family of cell-cell adhesion molecules segregate cells into tissues during embryonic development, and their expression in tumors can be used to trace the histogenesis of tumor cells. Because the surface epithelium of the ovary is a modified mesothelium, we speculated that the expression of E (epithelial)-cadherin and N (neural, mesodermal)-cadherin may provide clues about the controversial origin of common epithelial ovarian tumors. Immunohistochemistry was performed in paraffin sections using well-characterized monoclonal antibodies to E- and N-cadherin and heat-induced antigen-retrieval methods. We found that serous and endometrioid tumors express both E- and N-cadherin. In contrast, mucinous tumors strongly express E-cadherin, but no N-cadherin. The presence of N-cadherin in serous and endometrioid tumors traces their origin to the mesoderm-derived ovarian surface epithelium. The absence of N-cadherin in mucinous tumors clearly distinguishes them from the former, suggesting histogenesis from a cell lineage other than the ovarian surface epithelium or aberrant differentiation mechanisms associated with neoplastic transformation.

Citing Articles

Dimethyl Sulfoxide: A Bio-Friendly or Bio-Hazard Chemical? The Effect of DMSO in Human Fibroblast-like Synoviocytes.

Gallardo-Villagran M, Paulus L, Leger D, Therrien B, Liagre B Molecules. 2022; 27(14).

PMID: 35889344 PMC: 9318029. DOI: 10.3390/molecules27144472.


High N-Cadherin Protein Expression in Ovarian Cancer Predicts Poor Survival and Triggers Cell Invasion.

Assidi M Front Oncol. 2022; 12:870820.

PMID: 35574323 PMC: 9096138. DOI: 10.3389/fonc.2022.870820.


Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy.

Sheta R, Bachvarova M, Plante M, Renaud M, Sebastianelli A, Gregoire J J Transl Med. 2020; 18(1):439.

PMID: 33213473 PMC: 7678187. DOI: 10.1186/s12967-020-02613-4.


EMT, MET, Plasticity, and Tumor Metastasis.

Bakir B, Chiarella A, Pitarresi J, Rustgi A Trends Cell Biol. 2020; 30(10):764-776.

PMID: 32800658 PMC: 7647095. DOI: 10.1016/j.tcb.2020.07.003.


The role of glycogen synthase kinase 3 (GSK3) in cancer with emphasis on ovarian cancer development and progression: A comprehensive review.

Glibo M, Serman A, Karin-Kujundzic V, Bekavac Vlatkovic I, Miskovic B, Vranic S Bosn J Basic Med Sci. 2020; 21(1):5-18.

PMID: 32767962 PMC: 7861620. DOI: 10.17305/bjbms.2020.5036.